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Low serum klotho concentration 
is associated with worse cognition, 
psychological components 
of frailty, dependence, and falls 
in nursing home residents
Begoña Sanz1*, Haritz Arrieta2, Chloe Rezola‑Pardo1,3, Ainhoa Fernández‑Atutxa4, 
Jon Garin‑Balerdi5, Nagore Arizaga 1,6, Ana Rodriguez‑Larrad1 & Jon Irazusta1
Serum alpha‑klotho (s‑klotho) protein has been linked with lifespan, and low concentrations of 
s‑klotho have been associated with worse physical and cognitive outcomes. Although its significance 
in aging remains unclear, s‑klotho has been proposed as a molecular biomarker of frailty and 
dependence. This study is a secondary analysis of data from a clinical trial performed in a population 
of 103 older individuals living in 10 nursing homes in Gipuzkoa (Spain). We aimed to elucidate 
associations between s‑klotho (as measured by enzyme‑linked immunosorbent assay) and body 
composition, physical fitness, and cognition, as well as frailty and dependence (determined using 
validated tests and scales). In addition, we investigated the association of s‑klotho concentration with 
falls in the six months following the initial assessment. Low s‑klotho levels were associated with a 
lower score in the psychological component of the Tilburg Frailty Indicator, a worse score in the Coding 
Wechsler Adult Intelligence Scale, and a greater dependence in activities of daily living. Moreover, 
participants with lower s‑klotho concentrations suffered more falls during the 6 months after the 
assessment. Future translational research should aim to validate klotho’s putative role as a biomarker 
that could identify the risk of aging‑related adverse events in clinical practice.
Alpha-klotho is a transmembrane protein that is primarily expressed in the kidney and the choroid plexus of the 
 brain1 and can be cleaved and released in a soluble form (s-klotho) that acts as a hormone on tissues and cells that 
do not express the klotho (KL) gene, which encodes alpha-klotho2. Kuro-o et al.3 found that mice lacking the KL 
gene showed aging-related characteristics such as arteriosclerosis, osteoporosis, skin atrophy and emphysema 
and died prematurely. In the same vein, other authors have demonstrated that overexpression of KL can extend 
life span in  mice4. In humans, s-klotho also seems to be crucial in the pathophysiology of age-related  disorders3 
and lower plasma klotho concentration has been associated with a higher risk of  mortality5, however, its sig-
nificance in aging remains to be  elucidated6. Evidence suggests that s-klotho concentration can be determined 
both by genetic variations independent of  aging7 or by downregulation via aging-driven  mechanisms8,9 (Fig. 1a).
Although s-klotho plays a key role in energy  metabolism10, investigation of the relationship between klotho 
and physical fitness is scarcer in aged populations than in other population  groups11. However, studies about the 
association of s-klotho levels with physical fitness in older or middle-aged adults point in the same direction: 
low s-klotho has been associated with poor  grip12, decreased lower limb  strength13,14 and  dependence15 in older 
adults and with poor physical fitness in middle-aged sedentary  adults16.
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S-klotho is also secreted in the brain, and klotho-deficient mice demonstrated brain  atrophy3, difficulty 
in  learning17, fewer hippocampal synapses, axonal transport disorders, hippocampal  neurodegeneration18 and 
 demyelination19. Accordingly, other authors found that mice overexpressing the KL gene showed better cognitive 
functioning and performance on memory  tasks19. The involvement of klotho in calcium  transport20 could explain 
its association with cognitive  function21. In humans, lower klotho concentration has been associated with worse 
cognitive  function21,22,  neurodegeneration22, and  demyelination17. Klotho concentration was lower in cerebro-
spinal fluid collected from patients with Alzheimer’s disease compared to samples from a control  population8, 
and in patients with multiple sclerosis, lower klotho was associated with  disability23. These results support the 
positive role of klotho in the central nervous system not only in mice, but also in humans.
Activities of daily living (ADL) are often used as predictors of health and function in older  individuals24. Based 
on previous investigations from the same group showing that older adults with low serum klotho concentrations 
had poor skeletal muscle strength and were at a higher risk of mortality, Crasto et al.15 hypothesized that klotho 
was associated with dependence. They found for the first time that plasma klotho is independently associated 
with disability in ADL in community-dwelling older  adults15.
Frailty is a geriatric syndrome that refers to an increase in vulnerability to adverse health  outcomes25,26, 
including falls, and leads to a loss of autonomy and  dependence27, diminishing individuals’ quality of  life15. 
Although there are few studies on the topic, some authors have found an association between lower klotho 
concentration and  frailty1,28,29, which is consistent with the role of klotho as an anti-aging hormone linked to 
muscle and cognition.
The risk of falling increases in older adults with low muscle strength and/or cognitive  deficits30. In addi-
tion, people living in nursing homes tend to have higher  risk31 and rates of  falling32 than those living in the 
 community33. Falls can result in injuries, giving rise to physical limitations,  dependence34, psychological 
 consequences35, and/or deterioration of quality of  life30. Moreover, falls constitute a major public health  problem36 
with a high impact on the economic cost of health and social  systems37.
Assessment of fall risk is challenging due to its complex  nature38. Identification of molecular biomarkers 
related to fall events may provide an approach for identifying individuals at risk and clues to the pathophysiologi-
cal mechanisms related to  falls34. Some biomolecules closely related to klotho, such as vitamin D and fibroblast 
growth factor 23 (FGF-23)39, have been associated with the risk of falls in older  populations40,41. However, to our 
knowledge, no studies have yet analyzed the ability of serum klotho concentration to predict falls.
The vast majority of published studies about klotho and aging are focused on single spheres such as physical 
fitness, cognition, dependence, or frailty. To the best of the authors’ knowledge, to date, no study has investi-
gated the role of klotho on aging from an integrative perspective. Thus, the present study aims to elucidate the 
Figure 1.  (a) Schematic representation of the determinants of s-klotho’s concentration in aging *7, **8,9 and (b) 
the hierarchical domains of aging ***42. (c) The objectives of this study: to ascertain the association of s-klotho 
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association of s-klotho with parameters related to several hierarchical domains of  aging42 (Fig. 1b) in a popula-
tion of older people living in nursing homes. In particular, we aimed to ascertain the association of s-klotho (1) 
with the phenotypic (physical fitness and cognition) and functional (frailty and dependence in ADL) domains 
of aging and (2) with falls in a six-month follow-up (Fig. 1c).
Materials and methods
Study design and participants. This is a secondary analysis of the baseline data from a randomized con-
trolled physical exercise intervention that included a 6-month follow-up for falls. The study was conducted at ten 
nursing homes in Gipuzkoa, Spain (ACTRN12616001044415), between October 2016 and July  201743. The study 
adheres to the STROBE guidelines. This study was approved by the Ethics Committee for Research in Humans 
(CEISH: M10/2016/105) and by the Ethics Committee for Research with Biological Agents of the University of 
the Basque Country (CEIAB: M30/2016/106). Written informed consent was provided by each participant. The 
results of this exercise intervention were published  previously44–46.
The primary study included 112 men and women living in nursing homes who met the following crite-
ria: ≥ 70 years old; scored ≥ 50 on the Barthel Index for Activities of Daily Living (0–100)47; scored ≥ 20 on 
the MEC-35 test (0–35), an adapted and validated version of the Mini Mental State Examination (MMSE) in 
 Spanish48; and were capable of standing up and walking independently for at least ten meters. In this secondary 
analysis, 103 available serum samples from the 112 total participants were analyzed.
Serum klotho concentration. Baseline blood samples were collected in the morning following an over-
night fast. Following collection, the tubes were centrifuged at 5000×g for 10 min. The serum obtained from each 
participant was stored in aliquots at − 80 °C for further analysis. A commercial enzyme-linked immunosorbent 
assay (ELISA) was performed to measure klotho serum concentration according to the manufacturer’s proto-
col (Human soluble α-Klotho Assay Kit JP27998, Immuno-Biological Laboratories Co., Ltd., Gunma, Japan). 
The quantification was performed spectrophotometrically using a FLUOstar OPTIMA Microplate Reader 
(ThermoFisher Scientific, Waltham, MA, USA) and Optima Control software version 2.20 (http:// www. tmd. 
ac. jp/ cmn/ gene/ center/ 0413F 0011A% 20% 20Soft ware% 20Man ual% 20OPT IMA% 20Part% 20II. pdf) (BMG 
LABTECH GmbH, Offenburg, Germany). Serum samples were measured in duplicate and averaged. Coefficient 
of variability (%CV) was calculated using the following formula: %CV = standard deviation/mean. Limits for 
%CV were set at 5% and 10% for intra-assay and inter-assay measurements. respectively. All calculated %CV 
values were within these limits.
Other analyzed variables. At the baseline of the intervention, sociodemographic data (sex, age and edu-
cation level) and Barthel Index  scores47 were recorded from the database of the nursing homes. The Barthel 
Index reflects dependence in activities of daily living (ADL), and its score ranges from 0 to 100, with lower scores 
indicating a higher degree of dependence.
Regarding anthropometry, waist and hip circumference were measured with a non-elastic anthropometric 
tape and measured to the nearest 0.1 cm. Height was measured with a Holtain stadiometer to the nearest 0.1 cm, 
and body mass was measured with an Omron digital scale to the nearest 0.1 kg. Body mass index (BMI) was 
calculated based on height and mass, and the waist-to-hip ratio was based on waist and hip circumferences. 
Percentages of muscle and fat were measured using a portable bioelectrical impedance analyzer (Bodystat BIA 
Quadscan 4000, BOSYSTAT LTD; Isle of Man, UK). This method was supported by the European Working Group 
on Sarcopenia in Older People (EWGSOP) as a valid and cost-effective alternative to dual X-ray absorptiometry 
(DXA)49.
Physical fitness was assessed through the handgrip strength test using a Jamar  dynamometer50, and aerobic 
capacity was evaluated with the 6-Min Walk test of the Senior Fitness  Test51. Dynamic balance was assessed with 
the Timed Up and Go  Test52, and static balance with the Berg Balance  Scale53. Lower limb function (static balance, 
walking velocity, and lower limb strength) was evaluated with the Short Physical Performance Battery (SPPB)54.
Global cognition was assessed using the Montreal Cognitive Assessment (MoCA)55, which included visuos-
patial/executive function, naming, attention, language, abstraction, delayed recall, and orientation. Trail Making 
Test  A56 was administered to evaluate executive function, and the Coding test was used to measure processing 
speed on the Wechsler Adult Intelligence Scale, Fourth Edition (WAIS IV)57. Higher scores on these scales 
indicate better cognitive functioning, with the exception of Trail Making Test A, in which higher scores indicate 
worse performance. The MoCA, Trail Making Test A and Coding cognitive tests require participants to see and 
draw. Therefore, participants with visual impairments or difficulties holding a pen were unable to perform (some 
of) these tests. Regarding Trail Making Test A, some of the participants were unable to finish the test; thus, no 
result was recorded. For these reasons, the number of participants in cognitive tests varies.
Frailty status was assessed with the Fried Frailty Index (FFI)25, the Tilburg Frailty Indicator (TFI)58, and the 
Clinical Frailty Scale (CFS)59. Frailty, according to the Fried’s frailty phenotype, was identified by the presence 
of three or more of the following signs/symptoms: unintended weight loss, exhaustion, weakness, slow gait 
speed, and low physical  activit25. The TFI contains 15 questions on physical, psychological, and social domains 
of frailty. Participants with a score of 5 or more were considered frail according to the  TFI58. For the CFS, frailty 
status is based on clinical judgment. Possible scores range from 1 to 9, and participants with a score of 6 points 
or higher were considered frail.
All of the tests were performed by accredited and experienced professionals in each area.
The number of falls suffered by each participant within six months after baseline was recorded from the 
database of the nursing homes.
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Statistical analyses. Statistical analysis was performed using SPSS version 24 (https:// www. ibm. com/ es- 
es/ analy tics/ spss- stati stics- softw are) (IBM, Chicago, IL, USA). The Kolmogorov–Smirnov test was used to test 
the normality of the data. When data were not normally distributed (s-klotho concentration, hand grip, Timed 
Up and Go test, all cognition tests, Barthel scale, frailty indicators), they were square root transformed before 
being analyzed using parametric tests. Qualitative variables are presented as n (%) and quantitative variables as 
mean ± SD. Due to the exploratory nature of this study, and in order to avoid type II errors, Bonferroni correc-
tion was not applied to the statistical  analysis60.
Pearson correlations were carried out to examine associations between s-klotho concentration and quan-
titative variables (age, anthropometry, physical fitness, cognition, Barthel Index and frailty scores). Due to the 
uneven distribution of the number of falls, its association with klotho was calculated using a univariate Poisson 
regression. Differences in s-klotho levels between groups based on qualitative variables (sex, education level, 
frailty status, assignation to the control or the intervention group for the exercise program and fallers vs. non 
fallers) were assessed using Student’s t-test.
Results were considered statistically significant at p < 0.05.
Ethics approval and consent to participate. This study was approved by the Ethics Committee for 
Research in Humans (CEISH: M10/2016/105) and by the Ethics Committee for Research with Biological Agents 
of the University of the Basque Country (CEIAB: M30/2016/106).
Results
Descriptive characteristics of the sample. Baseline descriptive data are shown in Table 1. The mean 
concentration of s-klotho was 0.97 (± 0.18) ng/ml. Of the 103 participants, 73 (70.9%) were women and 30 
(29.1%) were men, with an average age of 84.7 (± 6.96) years. Regarding frailty, for each tool employed (FFI, 
TFI, and CFS), the mean score, as well as the frailty status (no/yes), are shown. The number of falls during the 
6-month follow-up is also shown, as the number and percentage of participants who fell or not.
Association of s‑klotho with quantitative variables. Table  2 shows baseline Pearson’s (Table  2A) 
and Poisson’s (Table 2B) correlations of s-klotho with the quantitative variables analyzed. No association was 
observed between s-klotho concentration and age, anthropometry, or physical fitness. Regarding cognition, par-
ticipants with lower s-klotho levels showed a trend toward worse scores in cognition-related tests, with statistical 
significance in the coding test (WAIS IV), which reflects processing speed (r = 0.256, p = 0.012). Regarding the 
Barthel Index, lower s-klotho was associated with higher dependence in ADL (r = 0.253, p = 0.010). When ana-
lyzing frailty scores, the only association found was with the psychological components of the TFI, with lower 
klotho concentration being associated with higher scores in psychological components of frailty (r =− 0.231, 
p = 0.026). S-klotho was also negatively associated with the number of falls (B = − 3.311, p < 0.001).
Differences in s‑klotho within groups of qualitative variables. Table 3 shows the mean (± standard 
deviation) s-klotho concentration according to sex, education level, frailty status, assignation to the control or 
the intervention group for the exercise program and falling status during the 6-month follow-up. S-klotho levels 
were lower in participants who fell compared to those who did not fall (p = 0.037). No other statistically signifi-
cant differences were found for qualitative variables.
Discussion
In this study, we have analyzed serum klotho concentrations in a population of 103 older adults living in nursing 
homes. Lower s-klotho concentration was associated with lower processing speed (higher score in the coding 
test [WAIS IV]) and more dependence in ADL (lower score in the Barthel Index). In addition, participants with 
lower s-klotho levels showed a worse score in the psychological components of the TFI. However, no association 
was found with any other scores on frailty assessment tools, nor were any differences found between the frail 
and non-frail participants in any of the tools used. Participants with lower s-klotho levels suffered more falls in 
the six-month follow-up.
Due to the described role of klotho in preventing muscle  loss1, it could be predicted to be positively associated 
with parameters related to muscle and physical fitness. However, in our work, neither body composition nor 
scores in physical performance tests were associated with s-klotho. Other authors have described an association 
between lower s-klotho and less muscle  mass16. The disagreement between their results and those of our study 
could be due to the population studied (middle-aged sedentary adults vs. older people living in nursing homes) 
or in the method employed to determine body composition (DXA vs. bioelectrical impedance analyzer).
Regarding physical performance, lower s-klotho has been associated with less  strength12,13 and worse results 
in tests of physical  fitness14,15,61. This discordance between these results and ours could be due to the different 
populations under study, as these previous studies were conducted in general samples consisting of younger and 
fitter community-dwelling middle-aged14,16 or older  adults12–15. To our knowledge, no study on the analysis of 
s-klotho levels in populations living in nursing homes has yet been published.
Although the association of klotho with cognition is not yet well established in  humans15, lower s-klotho 
concentration has been associated with worse global cognitive  function15,21 and higher risk of cognitive  decline21. 
In our study, participants with lower serum s-klotho concentrations obtained worse results in cognition-related 
tests, although this association was only significant for the coding test. The coding test measures processing 
 speed57, whereas the Trail Making Test A reflects executive  function56. Similar results that linked global cognitive 
function but not executive function with s-klotho have been described by Shardell et al.21 in community-dwelling 
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older adults. Better cognition associated with enhanced expression of klotho has been demonstrated in animal 
 models3,7 as well as in  humans8,15,17,21,22; this is likely linked to the action of brain-secreted klotho on the structure 
of the  synapses18. Although the mechanisms underlying klotho’s regulation in the brain are still unknown, klotho 
has been proposed as a potential target for therapies aimed at cognitive  enhancement62.
Based on klotho’s functions and some preclinical and clinical evidence, Angulo et al.9 have proposed that its 
upregulation would prevent phenotypic characteristics of frailty in the elderly. Loss of function of serum s-klotho 
has also been described as a quantifiable biomarker on the continuum between frailty and  resilience28 and for 
frailty diagnosis and  stratification28. However, we did not observe differences in serum s-klotho concentrations 
between frail and non-frail older people living in nursing homes.
Despite the lack of association between klotho and frailty in our study, participants with lower s-klotho levels 
exhibited lower scores in the psychological components of the TFI. Psychological frailty encompasses cognitive, 
Table 1.  Baseline characteristics of the studied population. SD standard deviation.
Variables N
N (%)
Mean  ± SD





Age (years) 103 84.7  ± 7.0
Years of education 103
 ≤ 12 95 (92.2)
 > 12 8 (7.8)
Anthropometry
Body mass index (kg/m2) 100 28.5  ± 5.2
Fat (%) 100 46.7  ± 8.8
Muscle (%) 100 53.3  ± 8.8
Waist-to-hip ratio 100 0.98  ± .08
Physical fitness
Hand grip (kg) 101 20.4  ± 7.9
6 min walk test (m) 101 224.7  ± 96.9
Gait speed 4 m (m/s) 98 0.64  ± 0.24
Timed Up and Go Test (m/s) 100 0.32  ± 0.14
Berg Balance Scale (score 0–56) 98 44.7  ± 8.4
Short Physical Performance Battery (score 0–12) 98 5.8  ± 3.0
Cognition
Montreal Cognitive Assessment (score 0–30) 83 14.0  ± 1.7
Trail Making Test A (s) 57 128  ± 54.4
Coding Wechsler Adult Intelligence Scale (WAIS IV; score 0–30) 77 11.9  ± 8.9
Activities of daily living
Barthel Index (score 0–100) 103 81  ± 13
Frailty
Fried Frailty Index (score 0–5) 94 2.9  ± 1.1
No (< 3) 35 (37.2)
Yes (≥ 3) 59 (62.8)
Tilburg Frailty Indicator (score 0–15) 93 5.8  ± 3.0
No (< 5) 35 (37.6)
Yes (≥ 5) 58 (62.4)
Physical components (score 0–8) 93 3.3  ± 2.2
Psychological components (score 0–4) 93 1.7  ± 0.98
Social components (score 0–3) 93 0.78  ± 0.47
Clinical Frailty Scale (score 1–9) 101 5.7  ± 0.79
No (≤ 6) 40 (39.60)
Yes (> 6) 61 (60.40)
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mood, and motivational  components63, and some authors have found its association with mental health-related 
quality of  life64. In addition, De Roeck et al.65 have recently proposed that cognitive frailty can occur independent 
of the other frailty domains, including physical frailty, and can therefore be seen as a distinct concept. These con-
cepts and findings are in line with our result, in which s-klotho was associated with cognition and psychological 
components of the TFI, but not with the physical or clinical tools for identifying frailty.
The lack of significant associations of s-klotho with muscle-related variables and frailty could be explained by 
the suspicion that the biology and functions of klotho may be more complex than previously  hypothesized6,28,66. 
Thus, compensatory/resilient mechanisms could mask the consequences of changes in molecular levels on the 
phenotypic and functional  responses42. Moreover, most of the published studies on klotho are related to its serum 
concentration or its genetic expression. However, klotho is a multifunctional protein with enzymatic activity as a 
glucuronidase (EC: 3.2.1.31) hydrolyzing extracellular sugars and has great importance in signaling  pathways67. 
As it is able to perform multiple functions (hormone, enzyme, and receptor)66 that differ  mechanistically68, 
klotho could be considered a moonlighting enzyme. This could have consequences in the comprehension of its 
regulatory mechanisms and supposed functions and implications for the functionality of the organism.
Our results also show that individuals with lower s-klotho concentrations were more dependent in their 
performance of ADL. Similar results have been published by Crasto et al.15 in a population of community-
dwelling older men and women. The loss of independence is one of the ultimate consequences of age-associated 
decline, but the changes that occur with aging, from the molecular to the functional level, are interconnected 
in a hierarchical arrangement. Eventually, these changes are reflected at the physical, cognitive, and emotional 
levels, as well as in social functions and ADL, as a result of the interaction between entropic and compensatory 
 mechanisms42. However, literature about age-associated dependence and molecular biomarkers is scarce, and 
further insight is needed into possible biological mechanisms that may underlie risk of  disability15.
Table 2.  Correlations between s-klotho concentration and quantitative variables. A: Pearson correlations for 
sociodemographic data, anthropometry, physical fitness, cognition, activities of daily living and frailty scores. 
B: Poisson correlation for number of falls. CI Confidence interval.
A
[s-klotho] (ng/ml) N Pearson coefficient p-value
Sociodemographic data
Age (years) 103 − 0.009 0.928
Anthropometry
Body mass index (kg/m2) 100 − 0.125 0.215
Fat (%) 100 − 0.024 0.816
Muscle (%) 100 0.027 0.789
Waist-to-hip ratio 100 − 0.010 0.919
Physical fitness
Hand grip (kg) 103 0.025 0.805
6 min walk test (m) 101 − 0.017 0.867
Gait speed 4 m (m/s) 98 − 0.009 0.927
Timed Up and Go Test (m/s) 100 − 0.039 0.703
Berg Balance Scale (score 0–56) 98 0.040 0.693
Short Physical Fitness Battery (score 0–12) 98 0.025 0.806
Cognition
Montreal Cognitive Assessment (0–30 points) 83 0.175 0.115
Trail Making Test A (s) 57 − 0.172 0.200
Coding Wechsler Adult Intelligence Scale (WAIS IV; 0–30 points) 77 0.286 0.012
Activities of daily living
Barthel Index 103 0.253 0.010
Frailty
Fried Frailty Index (score 0–5) 94 − 0.045 0.667
Tilburg Frailty Indicator (score 0–11) 93 − 0.155 0.139
Physical components (score 0–8) 93 − 0.103 0.324
Psychological components (score 0–4) 93 − 0.231 0.026
Social components (score 0–3) 93 0.005 0.960
Clinical Frailty Scale (score 1–9) 101 − 0.136 0.175
B
Number of falls N Poisson coefficient 95% (CI) Wald Chi-square p-value
[s-klotho] (ng/ml) 80 − 3.311 (− 4.785/− 1.836) 19,369  < 0.001
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We found an independent association of participants with a lower concentration of s-klotho at baseline and 
falls throughout the six-month follow-up. This association was apparent both when analyzing the number of falls 
and when analyzing whether participants fell or not. Falls have a significant impact on health outcomes in the 
elderly and are associated with various factors, including impairments in cognition and dependence in  ADL38. 
Due to the consequences of falling, identifying fall prediction tools might lead to novel translational approaches 
from basic research to clinical practice.
Few studies have focused on the relationship between molecular biomarkers and  falls34, and to our knowledge, 
no study has yet analyzed the relationship between klotho and the risk of falling. However, there is evidence 
for associations between falling risk and two molecules closely related to klotho, vitamin D and FGF-2339, that 
could support our results. Vitamin D promotes secretion of circulating klotho  hormone39, and the metabolism 
of these molecules is tightly  associated39,67,69. Ensuring adequate vitamin D levels has been proposed as a strategy 
to reduce falls, although the results of studies investigating whether vitamin D supplementation can reduce the 
number of falls are  inconsistent36,40. Indeed, it has been shown that community-dwelling older women with 
lower serum vitamin D concentrations suffered more falls despite the absence of an association between physi-
cal performance and vitamin D  concentration70. These results are in line with the lack of an association between 
s-klotho levels and physical fitness -related parameters in our study, despite the former’s association with falls. 
Thus, as Uusi-Rasi et al. proposed for vitamin  D70, s-klotho could modulate individual fall risk, albeit partially. In 
contrast, FGF-23 is a bone-derived hormone that inhibits α-hydroxylase, reducing serum 1, 25-dihidroxyvitamin 
 D71, and α-klotho is a co-receptor for FGF-23 in the  kidney39. Although FGF-23 has anti-aging effects, it also has 
some "off-target" actions that could actually be pro-aging72. It has been proposed that these off-target FGF-23 
pathologies are opposed by secreted  klotho39. Higher serum FGF-23 levels were associated with an increased 
risk of falls in patients with chronic kidney  disease41. The opposite associations of klotho and FGF-23 with falls 
are in line with the opposing actions of klotho and FGF-23. Overall, these associations between biomolecules 
and falls support a role for the vitamin D/FGF-23/klotho system, which has been described as crucial for healthy 
aging, in the assessment of the risk of  falls39.
This study has some limitations, as the small sample size, the lack of information about the medications the 
participants were taking, and any cognitive decline during the 6-month follow-up could act as confounders in 
the analysis. Due to the exploratory nature of this study and in order to increase statistical power, Bonferroni 
correction was not applied to the statistical analysis. However, this omission may have increased the chance of 
type I error. Moreover, although the bioelectrical impedance analyzer is accepted by the EWGSOP for body 
composition measurement and is an economic and portable technology, we recognize that more accurate results 
could have been obtained if DXA had been used for body composition calculation. In addition, the analysis of 
Table 3.  Student’s t-test comparing s-klotho concentrations in groups based on sex, years of education, frailty 




t-value Cohen’s d p-valueMean  ± SD
Sociodemographic data
Sex
Women 30 0.97  ± 0.18
− 0.04 − 0.01 .968
Men 73 0.97  ± 0.19
Years of education
 ≤ 12 95 0.96  ± 0.18
− 0.79 − 0.29 .428
 > 12 8 1.01  ± 0.17
Frailty
Fried Frailty Index (score 0–5)
No (< 3) 35 0.96  ± 0.18
− 3.29 − 0.07 .743
Yes (≥ 3) 59 0.98  ± 0.19
Tilburg Frailty Indicator (score 0–11)
No (< 5) 35 0.99  ± 0.20
1.13 − 0.24 .263
Yes (≥ 5) 58 0.95  ± 0.16
Clinical Frailty Scale (score 1–9)
No (< 6) 40 1.00  ± 0.21
1.26 0.27 .213
Yes (≥ 6) 61 0.95  ± 0.15
Intervention group
No 52 0.99  ± 0.19
1.25 0.25 .215
Yes 51 0.94  ± 0.17
Falls (0–6 months)
No 46 0.99  ± 0.16
2.12 0.07 .037
Yes 34 0.92  ± 0.15
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other molecular biomarkers related to klotho metabolism, such as FGF-23 or vitamin D, could have shown a 
possible interaction as molecules implicated in the regulation of the physiopathology of falling risk.
Nonetheless, this study presents a novel analysis of serum klotho and its association with future falls, present-
ing a line of research that could be further pursued. The introduction of a low-cost, easily standardized diagnostic 
tool to estimate the probability of developing falls in the near future would be very useful for routine clinical 
practice. Promotion of research models from the molecular mechanisms to the functional domains of aging will 
provide valuable information on both the molecular pathway regulation level and the functional level, which is 
linked to successful aging. Last, but not least, the studied population should be considered a strength of this work, 
since people living in nursing homes have specific characteristics and high vulnerability and comprise a poorly 
studied population. In addition, this study provides knowledge from an integrative perspective on aging-related 
outcomes, from the molecular to the phenotypic and functional domains of aging.
In conclusion, in a population of nursing home residents, lower s-klotho concentration was associated with 
worse cognition, scores indicating frailty in the psychological domain of the TFI, higher dependence in ADL, 
and future falls. These findings provide new and valuable information about the supposed role of klotho as 
a molecular biomarker linked to aging-related adverse events. Further investigation should be conducted to 
validate the putative ability of klotho to predict falling. This future research should include panels of associated 
molecular biomarkers that could be easily translated into clinical practice.
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